Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group (2023)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1093/schbul/sbad030
- Subjects: TÉCNICA DELPHI; ESQUIZOFRENIA; TRANSTORNOS PSICÓTICOS; FARMACOTERAPIA
- Keywords: Delphi; Clozapine; Consensus; Schizophrenia
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Schizophrenia Bulletin
- ISSN: 0586-7614
- Volume/Número/Paginação/Ano: v. 49, n. 4, p. 962-972, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WAGNER, Elias et al. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, v. 49, n. 4, p. 962-972, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbad030. Acesso em: 17 fev. 2026. -
APA
Wagner, E., Siskind, D., Falkai, P., Howes, O., Correll, C., Lee, J., et al. (2023). Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, 49( 4), 962-972. doi:10.1093/schbul/sbad030 -
NLM
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1093/schbul/sbad030 -
Vancouver
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1093/schbul/sbad030 - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Informações sobre o DOI: 10.1093/schbul/sbad030 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003200820.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
